HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Energizer Q1

This article was originally published in The Rose Sheet

Executive Summary

Blade and razor sales grew 12% to $228.2 mil. in the fiscal first quarter (ended Dec. 31), driven by performances of Schick Quattro and Intuition, company reports Jan. 25. Profit for the division jumped 20% to $41.4 mil. Consolidated sales increased 8%, or 5% on a constant currency basis, to $875.9 mil., and net earnings were $121.7 mil., or $1.62 per diluted share, up 6% versus the prior year. Release of firm's first quarter results coincides with start of Ward Klein's tenure as CEO. Energizer announced Klein, who previously served as chief operating officer, would succeed CEO Pat Mulcahy last year (1"The Rose Sheet" Nov. 8, 2004, p. 7)...

You may also be interested in...



Energizer Exec Klein Likely To Offer Smooth Management Transition

Energizer chief operating officer and longtime executive Ward Klein will take over leadership of the firm as CEO, succeeding Pat Mulcahy, who will retire following the firm's annual shareholder meeting on Jan. 25, the firm announced Nov. 2

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Takeda, Astellas Found New JV To Support Japanese Bioventures

Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012781

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel